[
Effective March 1, 2016, AmeriHealth will have new preferred
providers for both our Direct Ship Drug Program and for intravenous and
subcutaneous immunoglobulin (IVIG/SCIG) drugs provided in the home. These
changes will not affect medical necessity criteria or coverage determinations
for our members.
Direct Ship Drug Program
Walgreens and PerformRx have been chosen as preferred providers for our
Direct Ship Drug Program. All requests for direct ship drugs will be fulfilled
by these providers, with the exception of Synagis®, which will
continue to be fulfilled by ACRO Pharmaceutical Services.
Providers who currently order drugs through the Direct Ship Drug Program
will be contacted in the next few weeks to ensure there are no gaps in drug
fulfillment.
For more information on ordering drugs through our Direct Ship Drug Program,
go to the
AmeriHealth New Jersey website or the AmeriHealth
Pennsylvania website.
Home infusion IVIG/SCIG
Option Care has been selected as the preferred provider for IVIG/SCIG drugs
given in the home. Members who receive IVIG/SCIG from home infusion vendors
that are not owned by a hospital or health system in the AmeriHealth provider
network will be transitioned to Option Care.
AmeriHealth recently sent letters to affected members who currently receive
these drugs notifying them of this change and detailing the transition plan of
service. Option Care will also provide outreach to these members to answer
questions and schedule appointments with an Option Care home infusion nurse. In
addition, Option Care will contact affected providers to answer questions and
obtain new prescriptions for our members prior to the March 1, 2016, transition
date.
Providers should talk to their AmeriHealth members who currently receive
IVIG/SCIG drugs to see if they have any questions or concerns.
Note: Members who currently receive IVIG/SCIG drugs through home
infusion vendors that are owned by a hospital or health system in the
AmeriHealth provider network will not be affected by this change.
]